Venous Thromboembolism Risk 5 Times Higher for IBD Patients Using Corticosteroid Therapy

Venous Thromboembolism Risk 5 Times Higher for IBD Patients Using Corticosteroid Therapy
A recent study from the University of Michigan led by Peter Higgins, found that compared with biologic therapy, corticosteroid therapy increases the risk in five-fold of venous thromboembolism in patients with inflammatory bowel disease. Evidence has established a strong association between inflammatory bowel disease (IBD) flares and the risk of venous thromboembolism (VTE) and pulmonary embolism.

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *